- Cardiovascular Systems (CSII +11.2%) posts double-digit gains following the company's FQ4 beat.
- Revenue growth was 26% for the period.
- FQ1 outlook: Net loss of $0.39-0.42/ share on revenue of $27.5-28.5M against consensus of a $0.31/ share loss on sales of $26.12M.
- Feltl upgrades the shares to Strong Buy.
- Conference call transcript